New Treatments for Infrapopliteal Disease: Devices, Techniques, and Outcomes So Far

详细信息    查看全文

• 作者：Ondina Bernstein (1)
  Nicholas Chalmers (1) nicholas.chalmers@cmft.nhs.uk
• 关键词：Angioplasty &#8211 ; Arterial intervention &#8211 ; Arteriosclerosis &#8211 ; Diabetes &#8211 ; Drug ; eluting stents &#8211 ; Peripheral vascular &#8211 ; Peripheral vascular disease &#8211 ; Revascularization &#8211 ; Stent graft &#8211 ; Stenting
• 刊名：CardioVascular and Interventional Radiology
• 出版年：2012
• 出版时间：August 2012
• 年：2012
• 卷：35
• 期：4
• 页码：715-724
• 全文大小：282.6 KB
• 参考文献：1. Peregrin JH, Koznar B, Kovac J (2010) PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome. Cardiovasc Intervent Radiol 33:720–725
  2. Graziani L, Silvestro A, Bertone V et al (2007) Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg 33:453–460
  3. Drueke TB (2008) Arterial intima and media calcification: distinct entities with different pathogenesis or all the same? Clin J Am Soc Nephrol 3:1583–1584
  4. Jude EB, Oyibo SO, Chalmers N, Boulton AJ (2001) Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care 24:1433–1437
  5. Sacks D, Marinelli DL, Martin LG et al (2003) Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. J Vasc Interv Radiol 14:S395–S404
  6. Hunt DL (2009) Diabetes: foot ulcers and amputations. Clin Evid (Online) 2009:0602
  7. Braakenburg A, Obdeijn MC, Feitz R et al (2006) The clinical efficacy and cost effectiveness of the vacuum-assisted closure technique in the management of acute and chronic wounds: a randomized controlled trial. Plast Reconstr Surg 118:390–397
  8. Andros G, Armstrong DG, Attinger CE et al (2006) Consensus statement on negative pressure wound therapy (VAC therapy) for the management of diabetic foot wounds. Ostomy Wound Manag (suppl):1–32
  9. Edwards J, Stapley S (2010) Debridement of diabetic foot ulcers. Cochrane Database Syst Rev 20(1):CD003556
  10. Brass EP, Anthony R, Dormandy J et al (2006) Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. J Vasc Surg 43:752–759
  11. Kim HR, Han SK, Rha SW et al (2011) Effect of percutaneous transluminal angioplasty on tissue oxygenation in ischemic diabetic feet. Wound Repair Regen 19:19–24
  12. Caselli A, Latini V, Lapenna A et al (2005) Transcutaneous oxygen tension monitoring after successful revascularization in diabetic patients with ischaemic foot ulcers. Diabet Med 22:460–465
  13. Romiti M, Albers M, Brochado-Neto FC et al (2008) Meta-analysis of infrapopliteal angioplasty for chronic limb ischaemia. J Vasc Surg 47:975–981
  14. Katsanos KN, Siablis D, Zeller T et al (2011) The ACHILLES study, a prospective, randomized, multicenter comparison of balloon angioplasty and CYPHER SELECT庐 plus stent implantation in the treatment of patients with ischemic infrapopliteal arterial disease. CIRSE Munich
  15. Mehta SR, Yusuf S, Peters RJ et al (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358(9281):527–533
  16. Brener SJ, Steinhubl SR, Berger PB et al (2007) Dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights from the CREDO trial. J Invasive Cardiol 19:287–290
  17. Iida O, Nanto S, Uematsu M et al (2008) Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions. J Vasc Surg 48:144–149
  18. Strobl FF, Bantleon R, Brechtel K et al (2011) Management of peripheral arterial interventions with mono or dual antiplatelet therapy: the MIRROR study. CIRSE Munich
  19. Wang J, Zhu YQ, Li MH et al (2011) Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia. J Vasc Interv Radiol 22:987–994
  20. Norgren L, Hiatt WR, Dormandy JA, TASC II Working Group et al (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 33(suppl 1):S63
  21. Taylor GI, Minabe T (1992) The angiosomes of the mammals and other vertebrates. Plast Reconstr Surg 89:397
  22. Attinger CE, Evans KK, Bulan E et al (2006) Angiosomes of the foot and ankle and clinical implications for limb salvage: reconstruction, incisions and revascularization. Plast Reconstr Surg 117(Supp l):261S–293S
  23. Neville RF, Attinger CE, Bulan EJ et al (2009) Revascularization of a specific angiosome for limb salvage: does the target artery matter? Ann Vasc Surg 23:367–373
  24. Alexandrescu V, Vincent G, Azdad K et al (2011) A reliable approach to diabetic neuroischemic foot wounds: below-the-knee angiosome-oriented angioplasty. J Endovasc Ther 18:376–387
  25. Iida O, Soga Y, Hirano K et al (2012) Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions. J Vasc Surg 55:363–370
  26. Balzer J, Khan V, Thalhammer A et al (2010) Below the knee PTA in critical limb ischemia results after 12 months: single centre experience. Eur J Radiol 75:37–42
  27. Falluji N, Mukherjee D (2011) Contemporary management of infrapopliteal peripheral arterial disease. Angiology 62:490–499
  28. Adam DJ, Beard JD, Cleveland T et al (2005) Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicenter, randomized controlled trial. Lancet 366(9501):1925–1934
  29. Schmidt A, Ulrich M, Winkler B et al (2010) Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease. Catheter Cardiovasc Interv 76:1047–1054
  30. Soderstrom MI, Arvela EM, Korhonen M et al (2010) Infrapopliteal percutaneous transluminal angioplasty versus bypass surgery as first-line strategies in critical leg ischemia. Ann Surg 252:765–773
  31. Schmidt A, Piorkowski M, Werner M et al (2011) First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol 58:1105–1109
  32. Liistro F, Angiolil P, Grottil S et al (2011) Drug eluting balloon for below the knee angioplasty evaluation: the DEBATE BTK study. http://content.onlinejacc.org/cgi/reprint/58/20SupplS/B157.pdf. Accessed November 2011
  33. McKinsey JF, Goldstein L, Khan HU et al (2008) Novel treatment of patients with lower extremity ischemia: use of percutaneous atherectomy in 579 lesions. Ann Surg 248:519–528
  34. Zeller T, Sixt S, Schwarzwalder U et al (2007) Two-year results after directional atherectomy of infrapopliteal arteries with the SilverHawk device. J Endovasc Ther 14:232–240
  35. Ramaiah V, Gammon R, Kiesz S et al (2006) Midterm outcomes from the TALON registry: treating peripheral with SilverHawk: outcomes collection. J Endovasc Ther 13:592–602
  36. Zeller T, Krankenberg H, Steinkamp H et al (2009) One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD trial. J Endovasc Ther 16:653–662
  37. Stoner MC, deFreitas DJ, Phade SV et al (2007) Mid-term results with laser atherectomy in the treatment of infrainguinal occlusive disease. J Vasc Surg 46:289–295
  38. Laird JR, Zeller T, Gray B et al (2006) Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicentre trial. J Endovasc Ther 13:1–11
  39. Das T (2009) Excimer laser-assisted angioplasty for infrainguinal artery disease. J Endovasc Ther 16(suppl II):II98–II104
  40. Safian RD, Niazi K, Runyon JP et al (2009) Orbital atherectomy for infrapopliteal disease: device concept and outcome data for the Oasis trial. Catheter Cardiovasc Interv 73:406–412
  41. Das TS, McNamara T, Gray B et al (2009) Primary cryoplasty therapy provides durable support for limb salvage in critical limb ischemia patients with infrapopliteal lesions: 12-month follow-up results from the BTK Chill trial. J Endovasc Ther 16(Suppl II):II19–II30
  42. Feiring AJ, Wesolowski AA, Lade S (2004) Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. J Am Coll Cardiol 44:2307–2314
  43. Bosiers M, Lioupis C, Deloose K et al (2009) Two-year outcome after Xpert stent implantation for treating below the knee lesions in critical limb ischemia. Vascular 17:1–8
  44. Donas KP, Torsello G, Schwindt A et al (2010) Below knee bare nitinol stent placement in high risk patients with critical limb ischemia is still durable after 24 months of follow up. J Vasc Surg 52:356–361
  45. Randon C, Jacobs B, De Ryck F et al (2010) Angioplasty or primary stenting for infrapopliteal lesions: results of a prospective randomized trial. Cardiovasc Intervent Radiol 33:260–269
  46. Rand T, Lammer J, Rabbia C et al (2011) Percutaneous transluminal angioplasty versus turbostatic carbon-coated stents in infrapopliteal arteries: InPeria II trial. Radiology 261:634–642
  47. Biondi-Zoccai GGL, Sangiorgi G, Lotrionte M et al (2009) Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther 16:251–260
  48. Morice MC, Serruys PW, Barragan P et al (2007) Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial. J Am Coll Cardiol 50:1299–1304
  49. Commeau P, Barragan P, Roquebert PO et al (2006) Sirolimus for below the knee lesions: mid-term results of SiroBTK study. Catheter Cardiovasc Interv 68:793–798
  50. Feiring AJ, Krahn RN, Nelson L et al (2010) Preventing leg amputations in critical limb ischaemia with below-the-knee drug-eluting stents. J Am Coll Cardiol 55:1580–1589
  51. Scheinert D, Ulrich M, Scheinert S et al (2006) Comparison of sirolimus-eluting versus bare-metal stents for the treatment of infrapopliteal obstruction. Eurointervention 2:169–174
  52. Siablis D, Karnabatidis D, Katsanos K et al (2009) Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol 20:1141–1150
  53. Karnabatidis D, Spiliopoulos S, Diamantopoulos A (2011) Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia. J Endovasc Ther 18:1–12
  54. Bosiers M, Scheinert D, Peeters P et al (2012) Randomised comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg 55:390–398
  55. Rastan A, Tepe G, Krankenberg H et al (2011) Sirolimus-eluting vs bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multicenter, randomized clinical trial. Eur Heart J 32:2274–2281
  56. Tepe G, Scmehl J, Heller S et al (2010) Drug eluting stents versus PTA with GP IIb/IIIa blockade below the knee in patients with current ulcers: the BELOW study. J Cardiovasc Surg (Torino) 51:203–212
  57. Martens JM, Knippenberg B, Vos JA et al (2009) Update on PADI trial: percutaneous transluminal angioplasty and drug eluting stents for infrapopliteal lesions in critical limb ischemia. J Vasc Surg 50:687–690
  58. Katsanos KN, Diamantopoulos A, Spiliopoulos S et al (2011) Cost-effectiveness analysis of infrapopliteal drug-eluting stents for critical limb ischemia treatment. CIRSE Munich
  59. Bosiers M, AMS INSIGHT Investigators (2009) AMS INSIGHT—absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis. Cardiovasc Intervent Radiol 32:424–435
• 作者单位：1. Department of Radiology, Manchester Royal Infirmary, Oxford Road, Manchester, M13 9WL UK
• ISSN：1432-086X

文摘

The use of endovascular treatment of infrapopliteal disease has increased in popularity in recent years. An improvement in technical success rates due to the availability of newer devices has fuelled an increased interest in the subject. The pathogenesis, indications for treatment, and outcome measures of infrapopliteal disease differ from larger vessel intervention. Diabetes and renal failure are prevalent. Neuropathy and venous disease contribute to the etiology of ulceration. Most interventions are undertaken for critical limb ischemia rather than claudication. Therefore, a range of conservative, pharmacological, and invasive therapies are provided. Conventional percutaneous transluminal angioplasty (PTA) using modern low-profile systems is associated with high technical success rates. However, initial data from recent randomized, controlled trials suggest that drug-eluting stents are consistently achieving improved patency over PTA alone or over bare metal stents. This review summarizes recent advances in the treatment of infrapopliteal disease.